Pfizer fined a record £84.2m for overcharging Pharmaceutical giant Pfizer has been fined a record £84.2 million for charging the NHS “excessive and unfair prices”.
The Competition and Markets Authority (CMA) imposed the fine, along with a £5.2 million fine on the distributor Flynn Pharma, after finding each broke competition law “by charging excessive and unfair prices in the UK” for the anti-epilepsy drug phenytoin sodium capsules.
The CMA has ordered the companies to reduce their prices, but Pfizer says it will appeal the decision. OnMedica
No comments:
Post a Comment